The last three years have seen spectacular changes in, and a revival of, the chemotherapeutic treatment of streptococcal infections. Domagk in 1935 showed that a red dye, the hydrochloride of 4'sulphamido-2:diamino-azobenzol, when administered orally prevented death in mice that had been inoculated intraperitoneally with hemolytic streptococci. This dye was marketed under the name of Prontosil and was immediately used and reported on by Colebrook and his co-workers (1936) in the treatment of streptococcal infections of labour and the puerperium. indicates the probability that the simpler derivatives (now classed as sulphanilamides) would prove to be the active principle of the azo dyes. He 
